KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AGRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Agile Therapeutics
(Updated on Apr 26, 2024)

Sell candidate since Apr 25, 2024 PDF

No changes to the price of Agile Therapeutics stock on the last trading day (Friday, 26th Apr 2024). During the last trading day the stock fluctuated 8.86% from a day low at $0.395 to a day high of $0.430. The price has risen in 6 of the last 10 days and is up by 9.88% over the past 2 weeks.

Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AGRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 01, 2024, and so far it has risen 48.15%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Agile Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.446. On a fall, the stock will find some support from the short-term average at $0.388. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Agile Therapeutics stock

Agile Therapeutics finds support from accumulated volume at $0.394 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0350 between high and low, or 8.86%. For the last week the stock has had daily average volatility of 10.09%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AGRX) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Agile Therapeutics to open at $0.408, and during the day (based on 14 day Average True Range), to move between $0.341 and $0.459, which gives a possible trading interval of +/-$0.0594 (+/-14.85%) up or down from last closing price. If Agile Therapeutics takes out the full calculated possible swing range there will be an estimated 29.71% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.400 (0.07%) than the support at $0.394 (1.50%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Agile Therapeutics stock A Buy?

Agile Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.638 Sell Candidate Unchanged

Predicted Opening Price for Agile Therapeutics of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$0.408 ( 2.08%) $0.400

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AGRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.443 10.83 %
R2 0.430 7.49 %
R1 0.422 5.43 %
Current price: 0.400
Support S1 0.395 -1.26 %
S2 0.387 -3.32 %
S3 0.373 -6.67 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0.420 5.04 %
R1 0.400 0.0750 %
Current price 0.400
Support S1 0.394 -1.50%
S2 0.370 -7.50%
S3 0.334 -16.50%

FAQ

What is the symbol for Agile Therapeutics Stock and on which exchange is it traded?
The symbol for Agile Therapeutics is AGRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Agile Therapeutics Stock?
Agile Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Agile Therapeutics Stock?
Agile Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Agile Therapeutics Stock.

What's the current price of Agile Therapeutics Stock?
As of the end of day on the Apr 26, 2024, the price of an Agile Therapeutics (AGRX) share was $0.400.

What is the 52-week high and low for Agile Therapeutics Stock?
The 52-week high for Agile Therapeutics Stock is $6.97 and the 52-week low is $0.200.

What is the market capitalization of Agile Therapeutics Stock?
As of the Apr 26, 2024, the market capitalization of Agile Therapeutics is 2.742M.

When is the next earnings date for Agile Therapeutics?
The upcoming earnings date for Agile Therapeutics is Jun 07, 2024.
Click to get the best stock tips daily for free!

About Agile Therapeutics

Agile Therapeutics Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to h... AGRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT